Маркеры, характеризующие гликемический статус и развитие нейрональных нарушений у пациентов с сахарным диабетом 1-го типа (1091720), страница 23
Текст из файла (страница 23)
– V.98(8). – P. 1369-1373117.vanEupenM.G., SchramM.T., ColhounH.M., ScheijenJ.L., StehouwerC.D., Schalkwijk C.G. Plasma levels of advanced glycation endproducts are associated with type1 diabetes and coronary artery calcification // Cardiovasc Diabetol. – 2013. - V. 12(1). – P. 149.118. Mácsai E., Takáts Z., Derzbach L., Körner A., Vásárhelyi B. Verification of skinautofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report //Diabetes Technol Ther. – 2013. - V.
15(3). - P. 269-272119. Ryle C., Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in humandiabetics // J. Neurol Sci. – 1995. – V. 129. - P. 62–68120.RequenaJ.R., PriceD.L., ThorpeS.R., BaynesJ.W.Measurement of pentosidine in biological samples // Methods Mol Med. – 2000. – V. 38. – P. 209-217121.
Kerkeni M., Saïdi A., Bouzidi H, et al. Pentosidine as a biomarker for microvascularcomplications in type 2 diabetic patients // Diab Vasc Dis Res. – 2013. – V. 10(3). - P. 239-245122. Sell D.R., Nagaraj R.H., Grandhee S.K., et al. Pentosidine: a molecular marker for thecumulative damage to proteins in diabetes, aging, and uremia // Diabetes Metab Rev.
– 1991. – V. 7. P. 239–251123. Rother K.I. Diabetes treatment-bridging the divide // N Engl J Med. – 2007. - V. 356. –P. 1499-1501124. Valcourt U., Merle B., Gineyts E., Viguet-Carrin S., Delmas P.D., Garnero P. Nonenzymatic glycation of bone collagen modifies osteoclastic activity and differentiation // J Biol Chem.– 2007. – V. 282. - P. 5691-5703125.
Dunn E.J., Philippou H., Ariëns R.A., Grant P.J. Molecular mechanisms involved in theresistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus // Diabetologia. –2006. – V. 49. - P. 1071-1080126. Lund T., Svindland A., Pepaj M. Jensen A.B., Berg J.P., Kilhovd B., Hanssen K.F.109Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elasticarteries of humans // Diab Vasc Dis Res. – 2011. - V. 8. - P. 284-294127. Said G., Guilbert M., Millerot-Serrurot E., Van Gulick L., Terryn C., Garnotel R.,Jeannesson P.
Impact of carbamylation and glycation of collagen type I on migration of HT1080human fibrosarcoma cells // Int J Oncol. – 2012. – V. 40. – P.1797-1804128. Min-Xin Fu, Kevin J. Wells-Knecht, James A. Blackledge, Timothy J. Lyons, SuzanneR. Thorpe, John W. Baynes. Glycation, glycoxidation, and cross-linking of collagen by glucose.Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. DIABETES , VOL. 43,1994, 676-683129. Toure F., Zahm J-M., Garnotel R., Lambert E., et.
al. Gillery and Ph. RIEU. Receptor foradvanced glycation end-products (RAGE) modulates neutrophil adhesion and migration onglycoxidated extracellular matrix.Biochem. J. (2008) 416, 255–261130. Wang Y., Dou C., Yuan C., Datta A. Development of an automated enzymatic assay forthe determination of glycated serum protein in human serum // Clin.
Chem. 2005. – V. 51. – P. 1991–1992.131. Lapolla A., Fedele D., Garbeglio M., Martano L., Tonani R., Seraglia R., Favretto D.,Fedrigo M.A., Traldi P. Matrix-assisted laser desorption/ionization mass spectrometry, enzymaticdigestion, and molecular modeling in the study of non-enzymatic glycation of IgG // J Am Soc MassSpectrom. 2000. - 11. - P. 153-159132. Vrdoljak A., Trescec A., Benko B., Hecimovic D., Simic M.
In vitro glycation of humanimmunoglobulin G // Clin Chim Acta. 2004. – V. 345(1-2). - P. 105-111133. Kennedy D.M, Skillen A.W., Self C.H. Glycation of monoclonal antibodies impairs theirability to bind antigen // Clin Exp Immunol. – 1994. - V. 98. - P. 245-251134. Bork P., Holm L., Sander C. The immunoglobulin fold. Structural classification,sequence patterns and common core // J Mol Biol. – 1994. – V. 242. – P. 309-320135. Austin G.E., Mullins R.H., Morin L.G. Non-enzymic glycation of individual plasmaproteins in normoglycemic and hyperglycemic patients // Clin Chem.
– 1987. - V. 33(12). - P. 2220-4136. Mashiba S., Uchida K., Okuda S., Tomita S. Measurement of glycated albumin by thenitroblue tetrazolium colorimetric method // Clin Chim Acta. – 1992. - V. 212(1-2). – P. 3-15137. Guerin-Dubourg A., Catan A., Bourdon E., Rondeau P. Structural modifications ofhuman albumin in diabetes // Diabetes Metab. – 2012. - V.38. – P.
171–178138. Cohen M. Measurement of circulating glycated proteins to monitor intermediate-term110changes in glycaemic control // Eur. J. Clin. Chem. Clin. Biochem. – 1992. – V. 30. - P. 851–859139. Lee E.Y., Lee B.W., Kim D., et al. Glycated albumin is a useful glycation index formonitoring fluctuating and poorly controlled type 2 diabetes patients // Acta Diabetol. – 2011. V. 48. –P. 167 –172140.
Armbruster D.A. Fructosamine: structure, analysis, and clinical usefulness. Clin. Chem1987;33. - P. 2153–2163141. Baker J.R., Zyzak D.V., Thorpe S.R., Baynes J.W. Chemistry of the fructosamine assay:D-glucosone is the product of oxidation of Amadori compounds // Clin Chem. – 1994. – V. 40. - P.1950–1955142. David A.
Armbruster. Fructosamine: Structure, Analysis, and Clinical Usefulnes //CLIN. CHEM. – 1987. – V. 33(12). – P. 2153-2163143.KobayashiK., YoshimotoK., HirauchiK., UchidaK.,A novel colorimetric method for determination of glycated protein based on 2-ketoglucose release withhydrazine // Biol. Pharm.
Bull. – 1993. – V. 16(2). – P. 195-198.144. Yatscoff R.W., Tevaarwerk G.J., MacDonald J.C. Quantification of nonenzymicallyglycated albumin and total serum protein by affinity chromatography // Clin. Chem. – 1984. - V. 30. P.446 –449.145. Poduslo J.F., Curran G.L. Increased permeability across the blood –nerve barrier ofalbumin glycated in vitro and in vivo from patients with diabetic polyneuropathy // Proc.
Nat.l Acad.Sci. USA. – 1992. - V. 89. – P. 2218–2222.146. Yasukawa K., Abe F., Shida N., Koizumi Y., Uchida T., Noguchi K., Shima K. Highperformance affinity chromatography system for the rapid, efficient assay of glycated albumin // J.Chromatogr. – 1992.
– V. 597(1-2). – P. 271-275.147. Takátsy A. Böddi K., Nagy L., et al. Enrichment of Amadori products derived from thenonenzymatic glycation of proteins using microscaleboronate affinity chromatography // Anal.Biochem. – 2009. – V. 93(1). – P. 8-22.148. Ikeda K., Sakamoto Y., Kawasaki Y., Miyake T., Tanaka K., Urata T., KatayamaY., Ueda S., Horiuchi S. Determination of glycated albumin by enzyme-linked boronate immunoassay(ELBIA) // Clin. Chem. – 1998. – V. 44(2).
– P. 256-263.149. Cohen M.P., Hud E. Measurement of plasma glycoalbumin levels with a monoclonalantibody based ELISA // J. Immunol. Methods. – 1989. V. 122. – P. 279–83.150. Kohzuma T., Koga M. Lucica GA-L glycated albumin assay kit. A new diagnostic test111for diabetes mellitus // Mol. Diagn. Ther.
– 2010. V. 14. – P. 49 –51.151. Dingari N.C., Horowitz G.L., Kang J.W., Dasari R.R., Barman I. Raman spectroscopyprovides a powerful diagnostic tool for accurate determination of albumin glycation // PloS. One.2012. – V. 7. - e32406.152. Marie A.L., Przybylski C., Gonnet F., Daniel R., Urbain R., Chevreux G., JorieuxS., Taverna M. Capillary zone electrophoresis and capillary electrophoresis-mass spectrometry foranalyzing qualitative and quantitative variations in therapeutic albumin // Anal.
Chim. Acta. – 2013. –V. 24 (800). – P. 103-110.153. Pereira Morais M.P., Mackay J.D., Bhamra S.K. et al. Analysis of protein glycationusing phenylboronate acrylamide gel electrophoresis // Proteomics. 2010. - V. 10. - P. 48 –58.154. Martin G.J., Rand J.S., Hickey S.A. Separation of serum glycated proteins by agarosegelelectrophoresis and nitroblue tetrazolium staining in diabetic and normal cats // Vet. Clin. Pathol. –2006. V.
35. – P. 307 –310.155. Zheng C.M., Ma W.Y., Wu C.C., Lu K.C. Glycated albumin in diabetic patients withchronic kidney disease // Clin. Chim. Acta 2012. – V. 413. P. 1555–1561.156. Guerin-Dubourg A., Catan A., Bourdon E., Rondeau P. Structural modifications ofhuman albumin in diabetes // Diabetes Metab. – 2012. – V. 38. – P. 171 –178157. Shaklai N., Garlick R.L., Bunn H.F. Nonenzymatic glycosylation of human serum albumin alters its conformation and function // J Biol Chem.
–1984 V. 259. - P. 3812–3817158. Али Хан М.В., Рашид З., Али Хан В., Али Р.. Биохимический, биофизический итермодинамический анализ сывороточного альбумина человека, гликированного in vivo //Биохимия. – 2007. - т. 72. - вып. 2. – C. 175-183159. Nakajou K., Watanabe H., Kragh-Hansen U., Maruyama T., Otagiri M. The effect ofglycation on the structure, function and biological fate of human serum albumin as revealed byrecombinant mutants // Biochim Biophys Acta. – 2003. V. 1623. - P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
